How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
about
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic reviewNew Therapeutic Approaches in Polycythemia VeraAlternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic reviewWhole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera.Burning feet in polycythemia vera - peripheral sensorimotor axonal neuropathy with erythromelalgia.Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control studyIncidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in KoreaEpidemiology of MPN: what do we know?Is it time to revisit contraindications to organ donation from donors with a JAK-2 mutation? Safe use of a liver allograft from a donor with essential thrombocythaemia.Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004-2013.Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study.Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls.Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.Minor allele frequency of myeloproliferative neoplasm mutations in the Irish blood donor population.The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark surveyPrevalence of the Janus kinase 2 V617F mutation in Philadelphia-negative myeloproliferative neoplasms in a Portuguese population.The MOSAICC study: Assessing feasibility for biological sample collection in epidemiology studies and comparison of DNA yields from saliva and whole blood samples.Bone marrow findings in blast phase of polycythemia vera.Detection of the Janus kinase 2 V617F mutation using a locked nucleic-acid, real-time polymerase chain reaction assay.The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.
P2860
Q24186703-94AEA301-5CCE-4270-AFEE-CA163728D266Q26795677-A6FA3226-D62E-4E2C-BC2F-CE56EE31E081Q33436416-558F8472-7047-4456-A64D-B0735A687378Q33582246-824FEF11-ED22-4883-89DA-F5199B03DCF7Q35063492-D1E141A4-037C-46A6-974B-04A2E458CE8BQ36941980-6819E1F5-636C-4D2D-8129-BAE48979B8D2Q37207980-BDCD1D86-FCE0-4735-ABD6-526522861C36Q38240406-25A7A0C4-DAAF-4F94-A554-5E755E4741BDQ39028515-6F655F5D-97FD-4706-B462-5DF9FB8185C8Q39041471-C1BB3497-C1E0-4332-B1A0-20F39E2D71BDQ39061404-A8246DE4-70C2-4DAF-B0AC-342F9BA59F45Q39321106-EA871D03-F2BA-416D-ACEA-FE57114C66BBQ39357992-2B9266B8-EA08-44E3-9CF1-5B88F5F9A6F4Q39513246-C0ED729B-CA5D-436C-82A7-59E12E9FEC55Q40587986-418F55F9-2E2A-4A8F-87B3-63668A1D9588Q40795436-DD88C591-25E0-418A-B1CA-6BA2C9E5C2AEQ40809137-B28DDB84-9693-4590-B8D5-369AA43DAD65Q40945373-C2BEEE85-77B6-492D-BE5C-34F373E9061EQ41480766-74D6EE70-662A-4641-95C4-0333A805224CQ41508203-D772B6CC-77D9-40DC-9A16-33AA26FB8369Q46886345-82384141-DFE0-4608-BF24-0234035F75F3Q47873964-A1E3FC3E-CE0E-4737-838B-6769E1C4D298Q49504954-C8497157-6B58-4518-9F2C-785DA560CC81Q49801859-8279C021-1E03-4B50-A097-60E0FB3B5E75Q55284640-5A6F5BB6-D7B9-4C0E-A0F0-0664EA4B84D9
P2860
How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
@en
type
label
How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
@en
prefLabel
How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
@en
P2093
P2860
P50
P356
P1476
How common are myeloproliferative neoplasms? A systematic review and meta-analysis
@en
P2093
Andrew S Duncombe
Glen J Titmarsh
Mary Frances McMullin
Mike Clarke
Ruben Mesa
Sarah Horan
P2860
P304
P356
10.1002/AJH.23690
P577
2014-06-01T00:00:00Z